Áreas de interés
Hundreds of studies using adipose-derived stem and regenerative cells (ADRCs)—from mice to large animals to humans—across a broad spectrum of conditions have reported safety and signals of effectiveness in improving symptoms, function and quality of life for patients with chronic degenerative diseases. [1] [2] [3]
The following are key examples of areas we are currently focusing on with the use of experimental adult stem cell treatments for patients that have been diagnosed with a terminal illness or severe chronic disease.
To learn more about becoming patient of AMBROSE Cell Therapy, please click here.
Autoimmune
Immune-mediated disorders such as rheumatoid arthritis, multiple sclerosis and lupus.
Ortopedia
Sports injuries, osteoarthritis, back pain and other musculoskeletal issues.
Neurológico
Including Parkinson’s, Alzheimer’s, traumatic brain injury and stroke.
Neuropathies
Dysfunction of peripheral nerves resulting in pain, numbness and loss of function.
Diabetes
Both Type 1 and Type 2 diabetes as well as related complications and symptoms.
Enfermedad renal
Chronic kidney disease or failure leading to the gradual loss of function of the organs.
IBD
Inflammatory bowel diseases including ulcerative colitis, Crohn’s and IBS.
Salud masculina
Issues affecting men including benign prostatic hyperplasia, ED and others.
Lesión medular
Our goal is improvement in symptoms, function and quality of life after Spinal cord injuries.
[1]JK Fraser PhD y S. Kesten MD Células regenerativas autólogas derivadas de tejido adiposo: Una plataforma para aplicaciones terapéuticas Advanced Wound Healing Surgical Technology International XXIX
[2] A Nguyen, A et al Fracción vascular estromal: ¿Una realidad regenerativa? Parte 1: Conceptos actuales y revisión de la literatura Journal of Plastic, Reconstructive & Aesthetic Surgery (2016) 69, 170e179
[3] Guo et al Fracción vascular estromal: ¿Una realidad regenerativa? Parte 2: Conceptos actuales y revisión de la literatura Journal of Plastic, Reconstructive & Aesthetic Surgery (2016) 69, 180e188.
